OliX is a clinical stage biotechnology company, based on our own proprietary
RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Since the discovery of a RNAi technology, it has been widely recognized as the third drug development platform after small molecule and protein(antibody) drugs, which is now changing the paradigm of a therapeutic development.
Upgrade this company profile// Update & customize all content. Ask PharmaCompass, click HERE.